Evidence map›Paper›PMID 34557654›Full record

ArticleAnimal models and experimental medicine2021

Introduction of protocols for mass production of

Mohammad Saleh Bahreini, Mohammad Nohtani, Amir Masoud Salemi, Mehdi Mirzaeipour, Naghmeh Dastan, Sara Bajelan, Qasem Asgari

Open access · diamondAbstract read
In one paragraph

Article in Animal models and experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Parallel Propagation ofPathogens (Basel, Switzerland) · 2022
    Article
  2. Synthesis and anti-Annals of medicine and surgery (2012) · 2022
    Article
  3. Introduction of protocols for mass production ofAnimal models and experimental medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mohammad Saleh BahreiniDepartment of Medical Parasitology and Mycology School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID 0000-0001-9638-2522
Mohammad NohtaniDepartment of Medical Parasitology and Mycology School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Amir Masoud SalemiDepartment of Medical Parasitology and Mycology School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Mehdi MirzaeipourDepartment of Medical Parasitology and Mycology School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Naghmeh DastanDepartment of Medical Parasitology and Mycology School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Sara BajelanDepartment of Medical Parasitology and Mycology School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Qasem AsgariDepartment of Medical Parasitology and Mycology School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID 0000-0002-7945-2370
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Few investigations of genotype II of Methods: To develop an immunocompromised model and obtain tachyzoites of the PRU strain, BALB/c mice were orally treated with dexamethasone (10 mg/kg), cyclophosphamide (36 mg/kg), and cyclosporine (18 mg/kg) from 5 days prior to inoculation. Then, 10-15 tissue cysts of PRU strain were inoculated intraperitoneally into the mice. The tachyzoites obtained from mice were then cultivated in a HeLa cell culture. The resulting yield of tachyzoites was cryopreserved in 92% fetal calf serum, 8% dimethyl sulfoxide. The infectivity of these tachyzoites was evaluated using in vivo and in vitro examinations. Results: Numerous tachyzoites were observed in the peritoneal fluid of the immunosuppressed mice within 10-15 days after inoculation, and many tachyzoites were harvested from the HeLa cell culture. Trypan Blue staining showed 80% viability of the tachyzoites recovered from cryopreservation and this was confirmed by HeLa cell culture. In addition, mice infected intraperitoneally with the recovered tachyzoites presented with cysts in the brain after 2 months. Conclusion: We have developed an animal model for mass production of

Indexed as

ParasitesToxoplasmaAnimalsGenotypeHeLa CellsHumansMiceMice, Inbred BALB CBALB/cgenotype IIPRU straintachyzoitesToxoplasma gondii

Identifiers

PMID34557654
PMCPMC8446697
OpenAlexW3169882941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.